Du är här


myoscience: myoscience Named Winner of the 2014 Red Herring Top 100 North America Award

REDWOOD CITY, Calif., May 21, 2014 (GLOBE NEWSWIRE) -- California based
myoscience, inc., makers of the revolutionary iovera° system for treatment of
peripheral nerves, has been named a winner of the prestigious Red Herring
2014 Top 100 North America Award. As a winner, myoscience joins a short list
that honors the year's most promising private companies. Starting from a
field of over 3,000 candidates, myoscience was selected as a Top 100 winner
by Red Herring.

Award winners were selected using a rigorous evaluation process that included
both quantitative and qualitative criteria, such as financial performance,
technological innovation and intellectual property, management quality,
business model, customer footprint and market penetration.

Myoscience's groundbreaking iovera° treatment utilizes the body's natural
response to cold to deliver immediate results for both therapeutic and
aesthetic applications. The iovera° system is FDA cleared for the treatment
of pain in the United States and is approved in the European Union and Canada
for the treatment of wrinkles.

"In 2014, selecting the top 100 achievers was by no means a small feat," said
Alex Vieux, publisher and CEO of Red Herring. "In fact, we had the toughest
time in years because so many entrepreneurs had crossed significant
milestones so early. But after much thought, rigorous contemplation and
discussion, we narrowed our list down from all the candidates across North
America to the top 100 winners. We believe myoscience embodies the vision,
drive and innovation that define a successful entrepreneurial venture.
Myoscience should be proud of its accomplishment, as the competition was very

"We are proud of our team, grateful to our investors, and very honored to have
been selected for this highly coveted distinction," said myoscience CEO Clint
Carnell. "This selection further validates the hard-work and dedication of
our team in bringing this remarkable platform technology to patients around
the world."


Silicon Valley, California-based myoscience is a privately-held medical device
company committed to making its platform technology, Focused Cold Therapy,
the standard of care for the treatment of peripheral nerve conditions.
Focused Cold Therapy is the patented technology delivered by the ioveraº
system. The ioveraº system is currently approved in Europe and Canada for
temporary wrinkle reduction, temporary pain reduction and treatment of
dermatologic conditions, and is indicated in the United States for use in
pain management and general surgical use. For more information, please visit

© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are
trademarks of myoscience. MKT-0250 REV A

CONTACT: 1600 Seaport Blvd., Ste. 450 / Redwood City, CA
Tel: 650.474.2600 / iovera.com

Jay Patel / jay.patel@hypertonic.com


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: myoscience via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.